© 2025 Copyright – Merdury Biopharmaceutical Corporation
What We Offer
Contract Development and Pre-licensed Drug Technology Services
With the StackDose™ technology platform as the core, the company provides customized new drug development services for pharmaceutical companies, including dosage form design, 3D printing production equipment development and mass production, and assists pharmaceutical companies to create their own special process new drug production solutions.
Business Model
Merdury is committed to the innovation and development of 3D printed pharmaceuticals.
By embracing flexible collaboration models, we accelerate both technological advancement and product commercialization.
●Commissioned Technology Development
Merdury provides a comprehensive set of technical services to its partner pharmaceutical companies, ranging from the design of pharmaceutical formulations, customized development of StackDose™-based production equipment, to the licensing of equipment for mass production. The goal is to assist pharmaceutical companies to enhance the development capability and production technology to precisely control the release of drugs, and to promote the upgrading and restructuring of the pharmaceutical industry.
How We Collaborate
01/ Common Topics
Evaluating drug market potential and pharmaceutical plant space planning
02/ Signing of Contract
Signing and collection of development mileage
03/ Formulation Design
Design formulations, tablet structures and small-scale trial production based on drug characteristics
04/ Dedicated Equipment Development
Completed equipment construction and introduced formula trial production test
05/ Commercial Production
Authorize pharmaceutical factories to use the equipment for mass production and obtain drug licenses
06/ After-Sales Service
Rental, Maintenance, Supplies
●Raw Material Transfer Cooperation / Consignment Development
Merdury partners with an upstream MTA to develop drug-specific APIs and value-added medicines through the StackDose™ technology platform, which are then licensed and sold under a shared licensing program.
●Self-developed / Pre-licensed
Based on the StackDose™ technology platform, Merdury has developed its own product line, and in the future, it is expected to license the drugs to pharmaceutical companies for subsequent clinical trials and drug license application and acquisition.